Sign in
Taking peopleNo phase

Platelet-Rich Plasma for Erectile Dysfunction After Radical Prostatectomy

Key facts

Who runs it
Herlev and Gentofte Hospital
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
10 Nov 2026
Expected to end
Nov 2029
Type of study
Interventional, 2 groups
Treatments tested
  • Autologous Platelet Rich Plasma
  • saline solution (placebo)
Record updated
6 November 2026

Who can take part

Age
40 years to 75 years
Sex
Men only
Healthy volunteers
Cannot take part
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Age 40-75 years
  • Underwent unilateral or bilateral nerve-sparing radical prostatectomy between 1 and 3 years prior to the study
  • Good erectile function prior to surgery (IIEF-EF score ≥ 22)
  • Erectile dysfunction at inclusion with an IIEF-EF score < 22 without aids
  • Acceptance of a pause in other treatments for erectile dysfunction from 4 weeks before baseline (wash-out) until the 1-month follow-up after the last injection
  • In a stable relationship lasting at least 6 months with a desire for sexual activity
  • Able to understand and accept the study protocol

Who cannot take part

  • Other surgery or radiation therapy in the pelvic region
  • Use of anti-androgen medication
  • Peyronie's disease and/or previous episodes of priapism
  • Known psychiatric, neurological and/or endocrinological disease requiring medication (including hypogonadism with total testosterone <12 nmol/l)
  • Clinical or biochemical recurrence of prostate cancer
  • Severe cardiac disease in the form of unstable angina, NYHA class >II heart failure, uncontrolled arrhythmia, or severe symptomatic and/or significant valvular disease
  • Severe urinary incontinence preventing sexual activity (assessed by a physician at inclusion)
  • Excessive alcohol consumption (more than 21 units per week)

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex
  • Erectile dysfunction

This trial is currently available in Denmark.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will test whether injections of platelet-rich plasma (PRP) can improve erectile function in men with persistent erectile dysfunction (ED) at least 12 months after nerve-sparing radical prostatectomy for prostate cancer. Participants will be randomly assigned to receive either two PRP injections or two saline (placebo) injections into the penis, administered one month apart in a double-blind fashion. Erectile function will be assessed using the International Index of Erectile Function (IIEF) questionnaire at baseline and at 1, 3, 6, and 12 months after the last injection. The primary objective is to determine whether PRP improves the erectile function domain of the IIEF more than saline at one month after the last injection

The 2 groups in the trial

  • Platelet Rich Plasma (PRP)Treatment being tested

    A volume of 5 mL PRP will be administered in corpus cavernosum on two occasions, with a 1-month interval between injections

    Treatment: Autologous Platelet Rich Plasma

  • Saline Solution (Placebo)Other group

    A volume of 5 mL saline solution will be administered in corpus cavernosum on two occasions, with a 1-month interval between injections.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Treatment of Erectile Dysfunction After Radical Prostatectomy With Platelet-Rich Plasma Injections: a Randomized Controlled Trial
Criteria questions
Built from NCT07863388, who can take part
Record updated
6 November 2026